Hispa-NICE: A Pipe Dream or a Realistic and Necessary Initiative? Fernando Antoñanzas Editorial 23 April 2021 Pages: 481 - 483
Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review Alfredo PalaciosCarlos Rojas-RoqueFederico Augustovski Systematic Review 30 March 2021 Pages: 485 - 502
Utility Decrements Associated with Adult Overweight and Obesity in Australia: A Systematic Review and Meta-Analysis Joseph CarrelloAlison HayesThomas Lung Systematic Review 22 February 2021 Pages: 503 - 519
Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension Jing WuShitong XieJohn E. Brazier Original Research Article Open access 18 February 2021 Pages: 521 - 535
Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada Yong-Jin KimMark OremusSusan Horton Original Research Article 31 March 2021 Pages: 537 - 548
RETRACTED ARTICLE: The EQ-5D-5L Valuation Study in Egypt Sahar A. Al ShabasyMaggie M. AbbassiSamar F. Farid Original Research Article Open access 12 March 2021 Pages: 549 - 561
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland Nadine SchurKapil GudalaMatthias Schwenkglenks Original Research Article Open access 01 April 2021 Pages: 563 - 577
Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness Manuel NevesFernanda TrigoCatarina Geraldes Original Research Article Open access 31 January 2021 Pages: 579 - 587
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening Edna KeeneyHoward ThomSabina Sanghera Original Research Article Open access 02 April 2021 Pages: 589 - 600
Resource Utilization of Patients with Parkinson’s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study Christopher KruseSabrina KretschmerRichard Dodel Original Research Article Open access 19 March 2021 Pages: 601 - 615